Related Experiment Video
Updated: May 13, 2026
07:28
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Asthma medication delivery: mists and myths
Bart L Rottier1, Bruce K Rubin
1Department of Paediatric Pulmonology and Paediatric Allergology, Beatrix Children's Hospital, Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, University of Groningen, the Netherlands. b.l.rottier@umcg.nl
Paediatric Respiratory Reviews
|March 26, 2013
Summary
Asthma inhaler treatments, including inhaled corticosteroids (ICS) and bronchodilators, are often misused due to common myths. This study debunks these myths, explaining proper inhalation techniques for optimal drug delivery and asthma management.
Area of Science:
- Respiratory medicine
- Pharmacology
- Medical device technology
Background:
- Asthma management relies heavily on inhaled medications like inhaled corticosteroids (ICS) and bronchodilators.
- These drugs are delivered via pressurized metered dose inhalers (pMDI), dry powder inhalers (DPI), or nebulizers.
- Effective drug deposition in the airways is crucial for treatment success.
Purpose of the Study:
- To clarify the target areas for ICS and beta 2-agonists in asthma treatment.
- To investigate the factors influencing drug deposition, including particle size and inhalation technique.
- To identify and debunk common myths surrounding inhalation therapy.
Main Methods:
- Review of existing literature on asthma inhaler devices and drug delivery.
- Analysis of factors affecting particle deposition in the respiratory tract.
- Critical evaluation of common misconceptions regarding inhaler use.
Main Results:
- Drug deposition is influenced by both particle characteristics and patient inhalation maneuvers.
- Several prevalent myths about inhaler usage can lead to suboptimal therapeutic outcomes.
- Understanding the correct technique enhances the efficacy of inhaled asthma medications.
Conclusions:
- Debunking myths and promoting correct inhalation techniques are essential for improving asthma control.
- Educating patients on proper inhaler use can optimize the effectiveness of inhaled corticosteroids and bronchodilators.
- Evidence-based information is needed to correct misunderstandings about inhalation therapy.
Related Concept Videos
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...